Evropska unija - slovenščina - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologi - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Evropska unija - slovenščina - EMA (European Medicines Agency)

resilience biomanufacturing ireland limited - cepivo proti gripi (cel virion, inaktiviran), ki vsebuje antigen: a / vietnam / 1203/2004 (h5n1) - influenza, human; immunization; disease outbreaks - cepiva - preprečevanje gripe v uradno prijavljeni pandemični situaciji. pandemije gripe cepiva je treba uporabljati v skladu z uradnimi smernice.

Evropska unija - slovenščina - EMA (European Medicines Agency)

acino ag - klopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotična sredstva - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.

Evropska unija - slovenščina - EMA (European Medicines Agency)

bayer ag  - octocog alfa - hemofilija a - antihemoragije - zdravljenje in preventivo za krvavitev pri bolnikih s hemofilija a (prirojeno faktor viii pomanjkljivost). ta pripravek ne vsebuje von willebrand dejavnik in zato ni navedeno v von willebrand je bolezen.

Evropska unija - slovenščina - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland - prucalopride succinate - zaprtje - druga zdravila za zaprtje - resolor je indicirano za simptomatsko zdravljenje kronične zaprtje pri odraslih, pri katerih odvajala ne zagotovi ustrezno pomoč.

Evropska unija - slovenščina - EMA (European Medicines Agency)

takeda manufacturing austria ag - človeški protein c - purpura fulminans; protein c deficiency - antitrombotična sredstva - ceprotin is indicated for prophylaxis and treatment of  purpura fulminans  coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.

Evropska unija - slovenščina - EMA (European Medicines Agency)

bayer ag - octocog alfa - hemofilija a - antihemoragije - zdravljenje in profilaksa krvavitve pri bolnikih s hemofilijo a (prirojeno pomanjkanje faktorja viii). iblias se lahko uporablja za vse starostne skupine.

Evropska unija - slovenščina - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - hidrokortizon - nadledvična insuficienca - kortikosteroidi za sistemsko uporabo - zdravljenje nadledvične insuficience pri odraslih.

Evropska unija - slovenščina - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - gvanfacinijev klorid - motnja deficita pri hiperaktivnosti - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv mora biti uporabljena kot del celovite adhd zdravljenje programa, običajno vključujejo tudi psihološke, izobraževalnih in socialnih ukrepov.

Evropska unija - slovenščina - EMA (European Medicines Agency)

hexal ag  - rivastigmin - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - simptomatsko zdravljenje blage do zmerno hude alzheimerjeve demence. simptomatsko zdravljenje blage do zmerno hude demence pri bolnikih z idiopatsko parkinsonovo boleznijo.